GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
47.86
-0.16 (-0.33%)
Nov 28, 2025, 1:00 PM EST - Market closed
GSK Revenue
GSK had revenue of 8.55B GBP in the quarter ending September 30, 2025, with 6.68% growth. This brings the company's revenue in the last twelve months to 32.17B, up 2.73% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
32.17B GBP
Revenue Growth
+2.73%
P/S Ratio
2.20
Revenue / Employee
468,694 GBP
Employees
68,629
Market Cap
95.25B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GSK News
- 8 days ago - AnaptysBio shares tumble after legal fight with GSK over cancer drug license - Reuters
- 8 days ago - GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties - Benzinga
- 8 days ago - GSK, AnaptysBio Sue Each Other Over Cancer Drug License - WSJ
- 8 days ago - Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary - GlobeNewsWire
- 10 days ago - GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 11 days ago - Global drugmakers rush to boost US presence as tariff threat looms - Reuters
- 15 days ago - The Best Healthcare Stock to Hold in Uncertain Times - The Motley Fool
- 23 days ago - GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth - Reuters